US FDA approves Lilly’s Mounjaro to reduce cardiovascular risk
The US FDA approved Lilly’s Mounjaro to reduce cardiovascular risk.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.